IAA14 Antibody

What is IAA14 and what role does it play in auxin signaling pathways?

IAA14 (INDOLE-3-ACETIC ACID INDUCIBLE 14), also known as SOLITARY-ROOT (SLR)/IAA14, functions as a transcriptional repressor in the auxin signaling pathway of plants, particularly in Arabidopsis thaliana. In the absence of auxin, IAA14 forms a complex with AUXIN RESPONSE FACTOR 7 (ARF7) and ARF19 transcription factors, preventing them from activating the expression of target genes involved in lateral root formation.

This repressive function operates through a sophisticated mechanism involving:

• Direct interaction with ARF7 and ARF19 transcription factors

• Recruitment of the corepressor TOPLESS (TPL), which forms a bridge between IAA14 and components of the transcriptional machinery

• Association with the CDK8 kinase module (CKM) of the Mediator complex to block RNA polymerase II recruitment

Upon auxin perception, IAA14 is targeted for ubiquitination by the TIR1/AFB F-box proteins, leading to its degradation via the 26S proteasome. This degradation relieves the repression of ARF transcription factors, enabling the expression of auxin-responsive genes crucial for lateral root development .

Research has demonstrated that the stabilized slr-1 mutant of IAA14, which cannot be degraded in response to auxin, exhibits severe defects in lateral root formation due to constitutive repression of auxin-responsive genes .

How should I design immunoprecipitation experiments to study IAA14 protein interactions?

Designing effective immunoprecipitation (IP) experiments for IAA14 requires careful consideration of several factors:

Sample preparation:

• Use fresh plant tissue where IAA14 is highly expressed (young seedlings or roots)

• Include proteasome inhibitors (10-50 μM MG132) to prevent rapid IAA14 degradation

• Consider treatments with auxin antagonists like auxinole to stabilize IAA14

• Extract proteins using a buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Nonidet P-40 or Triton X-100

  • Protease inhibitor cocktail

  • 0.6 mM PMSF

IP strategy selection:

• For direct IP: Pre-immobilize antibodies on agarose or magnetic beads

• For indirect IP: Form immune complexes in the lysate first, then capture with beads

• Consider using epitope-tagged versions of IAA14 (FLAG, GFP) for higher specificity

Essential controls:

• Input sample (5-10% of total lysate before IP)

• Isotype-matched IgG as negative control

• Biological controls (IAA14 knockout or slr-1 mutant)

• Treatment controls (±auxin, ±proteasome inhibitors)

Detection methods:

For western blot detection after IP:

• Primary antibody: Anti-IAA14 or anti-tag antibody

• Secondary detection: Use TrueBlot secondary antibodies to reduce interference from IgG bands

• For studying ubiquitination: Perform IP with anti-IAA14/tag antibodies and detect with anti-ubiquitin antibodies

Co-IP experimental design:

For detecting IAA14 interactions with proteins like ARF7/19 or TPL:

• Use mild lysis conditions to preserve protein-protein interactions

• Consider reversible cross-linking to stabilize transient interactions

• Elute under non-denaturing conditions if subsequent activity assays are planned

Research has shown that including the auxin antagonist auxinole can enhance detection of IAA14 complexes by stabilizing the protein and its interactions with partners like TPL and Mediator components .

What are the best practices for detecting and validating IAA14 antibody specificity?

Validating IAA14 antibody specificity is critical for reliable experimental results. Follow these comprehensive approaches:

Primary validation methods:

• Western blot analysis:

  • Test against recombinant IAA14 protein as positive control

  • Compare signal between wild-type and IAA14 knockout plants

  • Verify signal increase in stabilized mutants (slr-1) compared to wild-type

  • Confirm signal reduction in auxin-treated samples (due to IAA14 degradation)

  • Observe signal increase with proteasome inhibitor treatment

• Peptide competition assay:

  • Pre-incubate antibody with excess purified IAA14 protein/peptide

  • Signal should be significantly reduced in western blot

  • Provides direct evidence of binding specificity

• Immunoprecipitation followed by mass spectrometry:

  • Perform IP with the IAA14 antibody

  • Analyze precipitated proteins by mass spectrometry

  • IAA14 should be the predominant protein identified

Cross-reactivity assessment:

• Test against recombinant proteins of other IAA family members

• Pay particular attention to closely related IAAs (IAA7, IAA17, IAA28)

• Consider using HuProt-like protein microarrays to assess binding to thousands of proteins simultaneously

Genetic validation approaches:

• Compare antibody reactivity in wild-type vs. IAA14 knockdown plants

• Test in transgenic plants expressing epitope-tagged IAA14

• Use the slr-1 mutant (stabilized IAA14) as a positive control

Expected IAA14 characteristics:

• Molecular weight: ~27-32 kDa for unmodified protein

• Ubiquitinated forms appear as higher molecular weight bands or smears

• Expression pattern should match known IAA14 domains (particularly in root pericycle cells)

• Signal should decrease rapidly following auxin treatment due to protein degradation

For immunohistochemistry applications, tissue localization pattern should match known IAA14 expression domains, with higher signal in tissues where IAA14 is active, such as pericycle cells in roots .

How can I optimize detection of low-abundance IAA14 protein in plant tissues?

IAA14 is often present at low levels due to rapid turnover through the ubiquitin-proteasome system. Here are strategies to enhance detection sensitivity:

Sample preparation optimization:

• Prevent degradation during extraction:

  • Add proteasome inhibitors (50 μM MG132) to extraction buffer

  • Include complete protease inhibitor cocktail with PMSF

  • Work quickly and maintain samples at 4°C throughout processing

  • Consider treating plants with auxin antagonists (auxinole) to stabilize IAA14

• Protein enrichment strategies:

  • Increase starting material (use 2-4g tissue for challenging samples)

  • Perform immunoprecipitation to concentrate IAA14 before western blotting

  • Use TCA/acetone precipitation to concentrate proteins

Western blot optimization:

• Membrane and transfer parameters:

  • Use PVDF membranes (higher protein binding capacity than nitrocellulose)

  • Optimize transfer conditions for small proteins (25-35 kDa range)

  • Consider semi-dry transfer for better efficiency with smaller proteins

• Detection system enhancement:

  • Use high-sensitivity ECL substrates

  • Try fluorescent secondary antibodies with digital imaging systems

  • Consider biotin-streptavidin amplification systems

  • Extend exposure time incrementally to capture weak signals

Antibody optimization:

• Primary antibody strategies:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend incubation time (overnight at 4°C)

  • Use concentrated antibody preparations or affinity-purified antibodies

  • Consider using biotinylated antibodies with streptavidin detection systems

• Signal amplification techniques:

  • Use polymer-based secondary antibody systems

  • Try tyramide signal amplification (TSA) for extreme sensitivity

  • Consider using protein A/G-HRP conjugates for cleaner detection

Alternative detection approaches:

• Mass spectrometry: Use targeted MS methods like Selected Reaction Monitoring (SRM)

• Proximity ligation assay: Detect IAA14 through interactions with known partners (ARF7/19, TPL)

• Use tagged versions: Express epitope-tagged IAA14 under its native promoter for easier detection

For particularly challenging samples, consider using a dual approach of immunoprecipitation followed by western blotting with a different antibody to maximize both sensitivity and specificity .

How can I use IAA14 antibodies to study auxin-induced degradation dynamics?

Studying IAA14 degradation dynamics provides crucial insights into auxin signaling kinetics. Here's a methodological approach using IAA14 antibodies:

Time-course experiment design:

• Treatment conditions:

  • Treat seedlings with auxin (NAA or IAA) for various time points (0, 5, 15, 30, 60, 120 minutes)

  • Extract proteins using buffers containing protease inhibitors

  • Include separate samples with proteasome inhibitors (MG132) as controls

• Analysis method:

  • Perform western blot to detect IAA14 levels over time

  • Quantify band intensities normalized to loading controls

  • Plot degradation curves to determine half-life (t₁/₂)

Cycloheximide chase assay:

• Pretreat seedlings with cycloheximide (CHX) to block protein synthesis

• Apply auxin and collect samples at different time points

• Compare degradation rates without the confounding effect of new protein synthesis

• This approach reveals the true degradation rate of existing IAA14 protein

Ubiquitination analysis:

• Experimental approach:

  • Immunoprecipitate IAA14 using specific antibodies

  • Perform western blot with anti-ubiquitin antibodies

  • Auxin treatment should increase detection of polyubiquitinated IAA14

  • Use linkage-specific antibodies (K48-linked) to characterize ubiquitin chains

• Expected results:

  • Higher molecular weight bands or smears indicate ubiquitinated IAA14

  • Intensity of ubiquitinated bands should increase rapidly after auxin treatment

  • K48-linked polyubiquitin chains are specific markers for proteasomal degradation

Data analysis and visualization:

• Create quantitative degradation profiles showing IAA14 levels over time

• Calculate degradation rate constants (k) from exponential decay curves

• Compare degradation parameters between wild-type and mutant plants

• Correlate IAA14 degradation with expression of auxin-responsive genes

Studies have demonstrated that IAA14 degradation dynamics are affected by mutations in ubiquitin processing enzymes. For example, in the tni mutant (a hypomorphic allele of UBIQUITIN SPECIFIC PROTEASE 14), there was excessive accumulation of poly-ubiquitinated proteins and reduced degradation of AUX/IAA proteins .

What approaches should I use to study IAA14 interactions with transcriptional regulators?

IAA14 functions through interactions with various transcriptional regulators. Here are methodological approaches to investigate these interactions:

Co-immunoprecipitation approaches:

• Standard Co-IP protocol:

  • Immunoprecipitate IAA14 using specific antibodies bound to beads

  • Identify co-precipitated proteins by western blotting or mass spectrometry

  • Include appropriate controls (IgG, input samples)

• Reciprocal Co-IP:

  • Perform Co-IP using antibodies against suspected interaction partners (ARF7, ARF19, TPL)

  • Detect IAA14 in the precipitated complexes

  • This confirms interactions from both perspectives

• Treatment variations:

  • Compare interactions ±auxin to identify auxin-dependent interactions

  • Include auxin antagonists (auxinole) to stabilize interactions

  • Use proteasome inhibitors to prevent degradation of interaction complexes

Identifying the protein interaction domains:

• Domain mapping:

  • Create deletion constructs of IAA14 lacking specific domains

  • Test each construct for interaction with partners

  • For example, the N-terminal domain of IAA14 is required for interaction with TPL

• Point mutation analysis:

  • Generate point mutations in key domains (e.g., the degron motif in domain II)

  • Analyze how mutations affect protein-protein interactions

  • The slr-1 mutation (in domain II) stabilizes IAA14 but may also affect interactions

Chromatin immunoprecipitation (ChIP) approaches:

• ChIP protocol optimization:

  • Cross-link protein-DNA complexes in intact plant tissues

  • Immunoprecipitate IAA14 or associated factors (ARF7/19)

  • Identify bound DNA regions by qPCR or sequencing

  • Include appropriate controls and multiple primer sets for target regions

• Sequential ChIP (Re-ChIP):

  • Perform first IP with anti-IAA14 antibodies

  • Elute complexes and perform second IP with antibodies against interaction partners

  • This confirms co-occupancy of the same DNA regions

Interpreting western blot results for IAA14 requires attention to several key aspects:

Expected band patterns:

• Unmodified IAA14:

  • Single band at approximately 27-32 kDa

  • Should be present in untreated wild-type plants

  • Signal typically diminishes rapidly after auxin treatment

• Modified forms:

  • Ubiquitinated IAA14: Higher molecular weight bands or smears (40-200 kDa)

  • Phosphorylated IAA14: Slight upward shift from the main band

  • Multiple bands may represent different post-translationally modified forms

Band intensity interpretation:

• Wild-type plants: Relatively low levels due to continuous turnover

• slr-1 mutant: Stronger signal due to stabilized IAA14

• Auxin-treated samples: Decreased signal intensity (confirm with time course)

• MG132-treated samples: Increased signal due to proteasome inhibition

• Auxinole-treated samples: Increased signal due to blocked TIR1-IAA14 interaction

Troubleshooting band patterns:

• No detectable band:

  • Possible rapid degradation: Add proteasome inhibitors during extraction

  • Low abundance: Increase starting material or concentrate proteins

  • Antibody sensitivity: Try more sensitive detection methods

• Multiple non-specific bands:

  • Cross-reactivity with other IAA proteins: Validate with knockout controls

  • Non-specific binding: Optimize blocking and washing conditions

  • Degradation products: Add protease inhibitors during extraction

• Unexpected high molecular weight bands:

  • Ubiquitinated forms: Confirm with anti-ubiquitin antibodies

  • Protein aggregates: Add reducing agents to sample buffer

  • Cross-linked complexes: Ensure complete denaturation of samples

Controls interpretation:

• Input samples: Should show consistent IAA14 signal before IP

• IgG control: Should show no band at IAA14 expected size

• Loading controls: Should show consistent intensity across samples

For quantitative analysis, normalize IAA14 band intensity to appropriate loading controls (actin, tubulin, or GAPDH) and compare relative abundance between samples. When studying IAA14 degradation dynamics, plotting normalized intensity against time can reveal degradation kinetics parameters .

What are the best approaches to study IAA14 interactions with the ubiquitin-proteasome system?

Investigating IAA14 interactions with the ubiquitin-proteasome system requires specific experimental approaches:

Ubiquitination assays:

• In vivo ubiquitination detection:

  • Express tagged IAA14 in plants (e.g., FLAG-IAA14)

  • Treat with proteasome inhibitors (MG132) to prevent degradation

  • Immunoprecipitate IAA14 using tag-specific antibodies

  • Detect ubiquitination by western blot with anti-ubiquitin antibodies

  • Compare patterns with and without auxin treatment

• Ubiquitin linkage characterization:

  • Use linkage-specific antibodies (anti-K48, anti-K63)

  • K48-linked chains typically target proteins for proteasomal degradation

  • Western blot analysis can reveal the predominant linkage types

Proteasome interaction studies:

• Co-immunoprecipitation approaches:

  • Immunoprecipitate IAA14 and probe for proteasome subunits

  • Alternatively, pull down proteasome components and detect IAA14

  • Include treatments with auxin, MG132, or both

  • Use appropriate controls (IgG, input samples)

• Cycloheximide chase assays:

  • Pretreat plants with cycloheximide to block protein synthesis

  • Apply auxin ± proteasome inhibitors

  • Monitor IAA14 degradation over time by western blot

  • Calculate half-life and degradation kinetics parameters

TIR1/AFB interaction analysis:

• Pull-down assays:

  • Express recombinant TIR1/AFB proteins

  • Perform pull-down with IAA14 ± auxin

  • Detect interaction by western blot

  • The interaction should be enhanced in the presence of auxin

• Auxin antagonist studies:

  • Treat samples with auxinole to block TIR1-IAA14 interaction

  • Compare ubiquitination and degradation patterns

  • This confirms the TIR1-dependent nature of the process

Deubiquitination studies:

• Deubiquitinating enzyme effects:

  • Study IAA14 stability in UBP14 mutant backgrounds (e.g., tni)

  • Compare ubiquitination patterns between wild-type and mutant plants

  • Monitor IAA14 degradation kinetics in response to auxin

• In vitro deubiquitination assays:

  • Purify ubiquitinated IAA14 from plants

  • Incubate with recombinant deubiquitinating enzymes

  • Monitor removal of ubiquitin chains by western blot

Research has demonstrated that IAA14 degradation is regulated by the ubiquitin-proteasome system, and mutations in ubiquitin processing enzymes like UBP14 can stabilize IAA14. The tni mutant (a hypomorphic allele of UBP14) showed excess accumulation of K48-linked polyubiquitinated proteins and reduced degradation of AUX/IAA proteins, confirming the role of ubiquitin recycling in regulating IAA14 stability .

How can I distinguish between IAA14 and other IAA family members in my experiments?

Distinguishing IAA14 from other IAA family members is challenging due to sequence similarities but can be achieved through several methodological approaches:

Antibody-based strategies:

• Epitope selection:

  • Use antibodies raised against unique IAA14 epitopes

  • Target the N-terminal domain, which shows greater sequence divergence

  • Validate specificity against recombinant IAA proteins

• Antibody validation:

  • Test against multiple IAA proteins to assess cross-reactivity

  • Perform peptide competition assays with IAA14-specific peptides

  • Include IAA14 knockout samples as negative controls

  • Use the slr-1 mutant with stabilized IAA14 as a positive control

Genetic approaches:

• Use of tagged IAA14:

  • Generate lines expressing epitope-tagged IAA14 under native promoter

  • Use tag-specific antibodies for detection and immunoprecipitation

  • Compare expression patterns between native and tagged proteins

  • Examples include FLAG-IAA14, GFP-IAA14, or HA-IAA14

• Mutant analysis:

  • Utilize the slr-1 mutant with stabilized IAA14 as a positive control

  • Compare with IAA14 knockout plants as negative controls

  • Include other IAA gain-of-function mutants for comparison (axr5-1/IAA1, shy2/IAA3)

Biochemical approaches:

• Protein interaction profiles:

  • IAA14 specifically interacts with ARF7 and ARF19

  • Perform co-IP experiments to identify specific interaction partners

  • Different IAA proteins have distinct ARF interaction preferences

• Expression domain analysis:

  • IAA14 has specific expression patterns, particularly in pericycle cells

  • Use promoter-reporter constructs to visualize expression domains

  • Compare with known expression patterns of other IAA genes

Mass spectrometry approaches:

• Peptide identification:

  • Identify IAA14-specific peptides for targeted MS detection

  • Focus on unique regions that differ from other IAA proteins

  • Use parallel reaction monitoring for high specificity

• Determine post-translational modifications:

  • Different IAA proteins may have distinct PTM patterns

  • Compare phosphorylation, ubiquitination, or other modifications

  • These differences can help distinguish between family members

Research has demonstrated that IAA14 has specific roles in lateral root development, and the slr-1 mutant shows distinct phenotypes that can be used to validate IAA14-specific effects in functional studies .

What methods can I use to study IAA14 post-translational modifications?

Investigating post-translational modifications (PTMs) of IAA14 requires specific techniques:

Phosphorylation analysis:

• Western blot detection:

  • Use Phos-tag SDS-PAGE to separate phosphorylated forms

  • Apply lambda phosphatase treatment to confirm phosphorylation

  • Compare migration patterns before and after phosphatase treatment

• Mass spectrometry approaches:

  • Immunoprecipitate IAA14 and perform MS analysis

  • Use phosphopeptide enrichment techniques (TiO2, IMAC)

  • Identify specific phosphorylation sites and their stoichiometry

• Kinase identification:

  • Test candidate kinases (MPK3, MPK6 have been implicated in IAA regulation)

  • Perform in vitro kinase reactions with recombinant IAA14

  • Detect phosphorylation by autoradiography or western blot

Ubiquitination analysis:

• Ubiquitination site mapping:

  • Immunoprecipitate IAA14 under denaturing conditions

  • Perform tryptic digestion and identify peptides with diglycine remnants

  • Compare ubiquitination patterns with and without auxin treatment

• Ubiquitin chain topology:

  • Use linkage-specific antibodies (K48, K63) to characterize chains

  • K48-linked chains typically target for proteasomal degradation

  • Western blot analysis can reveal the predominant linkage types

• Ubiquitination dynamics:

  • Track changes in ubiquitination following auxin treatment

  • Monitor both the rate and extent of ubiquitination

  • Correlate with degradation kinetics

Functional analysis of PTMs:

• Site-directed mutagenesis:

  • Generate phospho-mimetic (S→D, T→E) or phospho-null (S→A, T→A) mutants

  • Create lysine-to-arginine mutants to block ubiquitination

  • Test effects on protein stability, localization, and function

• Expression in plants:

  • Introduce mutated versions into IAA14 knockout background

  • Compare phenotypes to wild-type IAA14 complementation

  • Analyze protein stability and interaction properties

Experimental data presentation:

Research has shown that mutations in ubiquitin processing enzymes like UBP14 affect IAA14 stability. In the tni mutant, there was excessive accumulation of poly-ubiquitinated proteins and reduced degradation of AUX/IAA proteins, highlighting the importance of ubiquitination in regulating IAA14 function . Studies with other IAA proteins (like IAA15) have demonstrated that phosphorylation can also affect protein stability and function in the auxin signaling pathway .